Evidence map›Paper›PMID 32905711›Full record

ArticleDiabetes technology & therapeutics2021

The Digital/Virtual Diabetes Clinic: The Future Is Now-Recommendations from an International Panel on Diabetes Digital Technologies Introduction.

Moshe Phillip, Richard M Bergenstal, Kelly L Close, Thomas Danne, Satish K Garg, Lutz Heinemann, Irl B Hirsch, Boris P Kovatchev, Lori M Laffel, Viswanathan Mohan and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetes technology & therapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Observational
  5. Review
  6. Review
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Using digital tools to improve diabetes care in India with continuous glucose monitoring.Therapeutic advances in endocrinology and metabolism · 2025
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Moshe PhillipThe Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
Richard M BergenstalInternational Diabetes Center at Park Nicollet, Health Partners, Minneapolis, Minnesota, USA.
Kelly L CloseClose Concerns and diaTribe, San Francisco, California, USA.
Thomas DanneDiabetes Centre for Children and Adolescents, AUF DER BULT, Kinder-und Jugendkrankenhaus, Hannover, Germany.
Satish K GargUniversity of Colorado Denver and Barbara Davis Center for Diabetes, Aurora, Colorado, USA.
Lutz HeinemannScience Consulting in Diabetes, Neuss, Germany.
Irl B HirschDivision of Metabolism, Endocrinology, & Nutrition, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.
Boris P KovatchevCenter for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.
Lori M LaffelPediatric, Adolescent and Young Adult Section and Section on Clinical, Behavioral and Outcomes Research, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA.
Viswanathan MohanDr. Mohan's Diabetes Specialties Centre & Madras Diabetes Research Foundation, Chennai, India.
Christopher G ParkinCGParkin Communications, Inc., Henderson, Nevada, USA.
Tadej BattelinoDepartment of Pediatric Endocrinology, Diabetes and Metabolism, University Medical Centre-University Children's Hospital, and Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5M
NIDDK NIH HHS P30 DK036836
6 · The paper itself

Abstract

The increasing prevalence of diabetes, combined with a growing global shortage of health care professionals (HCP), necessitates the need to develop new approaches to diabetes care delivery to expand access to care, lessen the burden on people with diabetes, improve efficiencies, and reduce the unsustainable financial liability on health systems and payers. Use of digital diabetes technologies and telehealth protocols within a digital/virtual diabetes clinic has the potential to address these challenges. However, several issues must be resolved to move forward. In February 2020, organizers of the Advanced Technologies & Treatments for Diabetes Annual Conference convened an international panel of HCP, researchers, patient advocates, and industry representatives to review the status of digital diabetes technologies, characterize deficits in current technologies, and identify issues for consideration. Since that meeting, the importance of using telehealth and digital diabetes technologies has been demonstrated amid the global coronavirus disease (COVID-19) pandemic. This article summarizes the panel's discussion of the opportunities, obstacles, and requisites for advancing the use of these technologies as a standard of care for the management of diabetes.

Indexed as

Biomedical TechnologyDigital TechnologyTelemedicineBlood Glucose Self-MonitoringCommunicationCongresses as TopicDelivery of Health CareDiabetes MellitusElectronic Health RecordsHealth Services AccessibilityHumansInsulin Infusion SystemsMobile ApplicationsMonitoring, PhysiologicPhysician-Patient RelationsAGPConnected devicesDigital toolsTelemedicineType 1 diabetesType 2 diabetes

Identifiers

PMID32905711
PMCPMC8098767

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.